The trading price of Hims & Hers Health Inc (NYSE:HIMS) closed lower on Tuesday, March 04, and closing at $40.49, -0.47% lower than its previous close.
The company’s P/E ratio in the trailing 12-month period was 75.71. In examining the 52-week price action we see that the stock hit a 52-week high of $72.98 and a 52-week low of $11.20. Over the past month, the stock has gained 8.61% in value.
Hims & Hers Health Inc, whose market valuation is $9.00 billion at the time of this writing, is expected to release its quarterly earnings report in April. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by 0.21 per share this quarter, however they have predicted annual earnings per share of 1.07 for current year and 1.27 for next year.
Analysts have forecast the company to bring in revenue of 534.97M for the current quarter, with the likely lows of 529.24M and highs of 542.5M. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue is 2.32B.
On the technical side, indicators suggest HIMS has a 50% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned HIMS a recommendation rating is 13. Out of them, 5 rate it a Hold, while 7 recommend Buy, whereas 1 assign an Overweight rating. 0 analyst(s) have tagged Hims & Hers Health Inc (HIMS) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
If we dig deeper into the stock’s outlook, we see that the stock’s PEG is 2.47, which symbolizes a positive outlook. A quick review shows that HIMS’s price is currently -16.08% off the SMA20 and 10.94% off the SMA50. The RSI metric on the 14-day chart is currently showing 46.52, and weekly volatility stands at 13.86%. When measured over the past 30 days, the indicator reaches 13.52%. Hims & Hers Health Inc (NYSE:HIMS)’s beta value is currently sitting at 1.53, while the Average True Range indicator is currently displaying 6.38. With analysts defining $21-$68 as the low and high price targets, we arrive at a consensus price target of $25.5 for the trailing 12-month period. The current price is about 48.14% off the estimated low and -67.94% off the forecast high, based on this estimate. Investors will be thrilled if HIMS’s share price rises to $25.5, which is the median consensus price. At that level, HIMS’s share price would be 37.02% above current price.
To see how Hims & Hers Health Inc stock has been performing in comparison to its peers in the industry, here are the numbers: HIMS stock’s performance was -0.47% in the latest trading, and 210.51% in the past year. Hims & Hers Health Inc has a P/E ratio of 75.71.
An evaluation of the daily trading volume of Hims & Hers Health Inc (NYSE:HIMS) indicates that the 3-month average is 19.24 million.
Currently, records show that 212.46 million of the company’s shares remain outstanding. The insiders hold 18.32% of outstanding shares, whereas institutions hold 73.70%. However, since the stock’s price has seen 67.45% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
